Cargando…
Bone marrow suppression in pediatric patients with differentiated thyroid cancer following empirical radioiodine therapy
Pediatric patients with differentiated thyroid cancer (DTC) tend to have more advanced disease at presentation, for which more aggressive radioiodine (RAI) treatment would be commonly recommended. Several previous studies recommended dosimetry to calculate the optimal activity of RAI in pre-pubertal...
Autores principales: | Dong, Ping, Wang, Li, Huang, Rui, Li, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402880/ https://www.ncbi.nlm.nih.gov/pubmed/32756134 http://dx.doi.org/10.1097/MD.0000000000021398 |
Ejemplares similares
-
Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study
por: Wang, Renfei, et al.
Publicado: (2017) -
Incidentally polycystic kidney disease identified by SPECT/CT with post-therapy radioiodine scintigraphy in a patient with differentiated thyroid carcinoma: A case report
por: Mi, Yan-Xia, et al.
Publicado: (2017) -
Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by (18)F-FDG PET/CT: A clinical case report
por: Dong, Ping, et al.
Publicado: (2017) -
(18)F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration
por: Alam, Mohammed Shah, et al.
Publicado: (2016) -
Clinical role of (18)F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer
por: Tang, Xiaowei, et al.
Publicado: (2023)